Veradermics to Discuss Phase 3 Trial Results on Investor Call
Veradermics plans to review topline results from its Phase 3 ‘304’ VDPHL01 trial in males with mild-to-moderate pattern hair loss on an investor call and webcast scheduled for October 19, 2026, at 8:00 a.m. ET.
Story updates
10:01:02 PM UTC
SquawkNews
Veradermics, Incorporated will host a call and webcast on Oct. 19, 2026 at 8:00 am ET to review topline results from Part A of its Phase 3 ‘304’ trial of VDPHL01 in over 500 males with mild-to-moderate pattern hair loss.Material DetailsContext by AI AnalystThis is a late-stage inflection where pivo…